Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 220 entries
Sorted by: Best Match Show Resources per page
Changes in Burnout Among Oncology Physician Assistants Between 2015 and 2019.

JCO oncology practice

Tetzlaff ED, Hylton HM, Ruth KJ, Hasse Z, Hall MJ.
PMID: 34292762
JCO Oncol Pract. 2022 Jan;18(1):e47-e59. doi: 10.1200/OP.21.00051. Epub 2021 Jul 22.

PURPOSE: Burnout has significant implications for the individual provider, the oncology workforce, and the quality of care for patients with cancer. The primary aim of this study was to explore temporal changes in burnout among physician assistants (PAs) in...

Cite
Tetzlaff ED, Hylton HM, Ruth KJ, et al. Changes in Burnout Among Oncology Physician Assistants Between 2015 and 2019. JCO Oncol Pract. 2021;18(1):e47-e59doi: 10.1200/OP.21.00051.
Tetzlaff, E. D., Hylton, H. M., Ruth, K. J., Hasse, Z., & Hall, M. J. (2022). Changes in Burnout Among Oncology Physician Assistants Between 2015 and 2019. JCO oncology practice, 18(1), e47-e59. https://doi.org/10.1200/OP.21.00051
Tetzlaff, Eric D, et al. "Changes in Burnout Among Oncology Physician Assistants Between 2015 and 2019." JCO oncology practice vol. 18,1 (2022): e47-e59. doi: https://doi.org/10.1200/OP.21.00051
Tetzlaff ED, Hylton HM, Ruth KJ, Hasse Z, Hall MJ. Changes in Burnout Among Oncology Physician Assistants Between 2015 and 2019. JCO Oncol Pract. 2022 Jan;18(1):e47-e59. doi: 10.1200/OP.21.00051. Epub 2021 Jul 22. PMID: 34292762; PMCID: PMC8757962.
Copy Download .nbib Format: NLM
A randomized trial of exercise and diet on health-related quality of life in survivors of breast cancer with overweight or obesity.

Cancer

Brown JC, Sarwer DB, Troxel AB, Sturgeon K, DeMichele AM, Denlinger CS, Schmitz KH.
PMID: 34161602
Cancer. 2021 Oct 15;127(20):3856-3864. doi: 10.1002/cncr.33752. Epub 2021 Jun 23.

BACKGROUND: Obesity is a chronic, relapsing, and progressive disease; it is associated with poor health-related quality of life (HRQOL) in survivors of breast cancer.METHODS: In this 2 × 2 factorial trial, 351 survivors of breast cancer with overweight or...

Cite
Brown JC, Sarwer DB, Troxel AB, et al. A randomized trial of exercise and diet on health-related quality of life in survivors of breast cancer with overweight or obesity. Cancer. 2021;127(20):3856-3864doi: 10.1002/cncr.33752.
Brown, J. C., Sarwer, D. B., Troxel, A. B., Sturgeon, K., DeMichele, A. M., Denlinger, C. S., & Schmitz, K. H. (2021). A randomized trial of exercise and diet on health-related quality of life in survivors of breast cancer with overweight or obesity. Cancer, 127(20), 3856-3864. https://doi.org/10.1002/cncr.33752
Brown, Justin C, et al. "A randomized trial of exercise and diet on health-related quality of life in survivors of breast cancer with overweight or obesity." Cancer vol. 127,20 (2021): 3856-3864. doi: https://doi.org/10.1002/cncr.33752
Brown JC, Sarwer DB, Troxel AB, Sturgeon K, DeMichele AM, Denlinger CS, Schmitz KH. A randomized trial of exercise and diet on health-related quality of life in survivors of breast cancer with overweight or obesity. Cancer. 2021 Oct 15;127(20):3856-3864. doi: 10.1002/cncr.33752. Epub 2021 Jun 23. PMID: 34161602; PMCID: PMC8478822.
Copy Download .nbib Format: NLM
The E protein-TCF1 axis controls γδ T cell development and effector fate.

Cell reports

Fahl SP, Contreras AV, Verma A, Qiu X, Harly C, Radtke F, Zúñiga-Pflücker JC, Murre C, Xue HH, Sen JM, Wiest DL.
PMID: 33535043
Cell Rep. 2021 Feb 02;34(5):108716. doi: 10.1016/j.celrep.2021.108716.

TCF1 plays a critical role in T lineage commitment and the development of αβ lineage T cells, but its role in γδ T cell development remains poorly understood. Here, we reveal a regulatory axis where T cell receptor (TCR)...

Cite
Fahl SP, Contreras AV, Verma A, et al. The E protein-TCF1 axis controls γδ T cell development and effector fate. Cell Rep. 2021;34(5):108716doi: 10.1016/j.celrep.2021.108716.
Fahl, S. P., Contreras, A. V., Verma, A., Qiu, X., Harly, C., Radtke, F., Zúñiga-Pflücker, J. C., Murre, C., Xue, H. H., Sen, J. M., & Wiest, D. L. (2021). The E protein-TCF1 axis controls γδ T cell development and effector fate. Cell reports, 34(5), 108716. https://doi.org/10.1016/j.celrep.2021.108716
Fahl, Shawn P, et al. "The E protein-TCF1 axis controls γδ T cell development and effector fate." Cell reports vol. 34,5 (2021): 108716. doi: https://doi.org/10.1016/j.celrep.2021.108716
Fahl SP, Contreras AV, Verma A, Qiu X, Harly C, Radtke F, Zúñiga-Pflücker JC, Murre C, Xue HH, Sen JM, Wiest DL. The E protein-TCF1 axis controls γδ T cell development and effector fate. Cell Rep. 2021 Feb 02;34(5):108716. doi: 10.1016/j.celrep.2021.108716. PMID: 33535043; PMCID: PMC7919611.
Copy Download .nbib Format: NLM
Peroral endoscopic myotomy: techniques and outcomes.

Shanghai chest

Petrov RV, Fajardo RA, Bakhos CT, Abbas AE.
PMID: 34013165
Shanghai Chest. 2021 Apr;5. doi: 10.21037/shc.2020.02.02.

Achalasia is progressive neurodegenerative disorder of the esophagus, resulting in uncoordinated esophageal motility and failure of lower esophageal sphincter relaxation, leading to impaired swallowing. Surgical myotomy of the lower esophageal sphincter, either open or minimally invasive, has been a...

Cite
Petrov RV, Fajardo RA, Bakhos CT, et al. Peroral endoscopic myotomy: techniques and outcomes. Shanghai Chest. 2021;5doi: 10.21037/shc.2020.02.02.
Petrov, R. V., Fajardo, R. A., Bakhos, C. T., & Abbas, A. E. (2021). Peroral endoscopic myotomy: techniques and outcomes. Shanghai chest, 5. https://doi.org/10.21037/shc.2020.02.02
Petrov, Roman V, et al. "Peroral endoscopic myotomy: techniques and outcomes." Shanghai chest vol. 5 (2021). doi: https://doi.org/10.21037/shc.2020.02.02
Petrov RV, Fajardo RA, Bakhos CT, Abbas AE. Peroral endoscopic myotomy: techniques and outcomes. Shanghai Chest. 2021 Apr;5. doi: 10.21037/shc.2020.02.02. PMID: 34013165; PMCID: PMC8130836.
Copy Download .nbib Format: NLM
Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma.

Cancers

Pazina T, MacFarlane AW, Bernabei L, Dulaimi E, Kotcher R, Yam C, Bezman NA, Robbins MD, Ross EA, Campbell KS, Cohen AD.
PMID: 33435153
Cancers (Basel). 2021 Jan 10;13(2). doi: 10.3390/cancers13020226.

Accumulating evidence demonstrates important roles for natural killer (NK) cells in controlling multiple myeloma (MM). A prospective flow cytometry-based analysis of NK cells in the blood and bone marrow (BM) of MM patient subgroups was performed (smoldering (SMM), newly...

Cite
Pazina T, MacFarlane AW, Bernabei L, et al. Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma. Cancers (Basel). 2021;13(2)doi: 10.3390/cancers13020226.
Pazina, T., MacFarlane, A. W., Bernabei, L., Dulaimi, E., Kotcher, R., Yam, C., Bezman, N. A., Robbins, M. D., Ross, E. A., Campbell, K. S., & Cohen, A. D. (2021). Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma. Cancers, 13(2), . https://doi.org/10.3390/cancers13020226
Pazina, Tatiana, et al. "Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma." Cancers vol. 13,2 (2021). doi: https://doi.org/10.3390/cancers13020226
Pazina T, MacFarlane AW, Bernabei L, Dulaimi E, Kotcher R, Yam C, Bezman NA, Robbins MD, Ross EA, Campbell KS, Cohen AD. Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma. Cancers (Basel). 2021 Jan 10;13(2). doi: 10.3390/cancers13020226. PMID: 33435153; PMCID: PMC7827733.
Copy Download .nbib Format: NLM
Heterogeneity in head and neck cancer incidence among black populations from Africa, the Caribbean and the USA: Analysis of cancer registry data by the AC3.

Cancer epidemiology

Auguste A, Gathere S, Pinheiro PS, Adebamowo C, Akintola A, Alleyne-Mike K, Anderson SG, Ashing K, Awittor FK, Awuah B, Bhakkan B, Deloumeaux J, du Plessis M, Ekanem IA, Ekanem U, Ezeome E, Felix N, Gachii AK, Gaete S, Gibson T, Hage R, Harrison S, Igbinoba F, Iseh K, Kiptanui E, Korir A, Lawson-Myers HD, Llanos A, Luce D, McNaughton D, Odutola M, Omonisi A, Otu T, Peruvien J, Raheem N, Roach V, Sobers N, Uamburu N, Ragin C.
PMID: 34743058
Cancer Epidemiol. 2021 Dec;75:102053. doi: 10.1016/j.canep.2021.102053. Epub 2021 Nov 04.

BACKGROUND: Africa and the Caribbean are projected to have greater increases in Head and neck cancer (HNC) burden in comparison to North America and Europe. The knowledge needed to reinforce prevention in these populations is limited. We compared for...

Cite
Auguste A, Gathere S, Pinheiro PS, et al. Heterogeneity in head and neck cancer incidence among black populations from Africa, the Caribbean and the USA: Analysis of cancer registry data by the AC3. Cancer Epidemiol. 2021;75:102053doi: 10.1016/j.canep.2021.102053.
Auguste, A., Gathere, S., Pinheiro, P. S., Adebamowo, C., Akintola, A., Alleyne-Mike, K., Anderson, S. G., Ashing, K., Awittor, F. K., Awuah, B., Bhakkan, B., Deloumeaux, J., du Plessis, M., Ekanem, I. A., Ekanem, U., Ezeome, E., Felix, N., Gachii, A. K., Gaete, S., Gibson, T., Hage, R., Harrison, S., Igbinoba, F., Iseh, K., Kiptanui, E., Korir, A., Lawson-Myers, H. D., Llanos, A., Luce, D., McNaughton, D., Odutola, M., Omonisi, A., Otu, T., Peruvien, J., Raheem, N., Roach, V., Sobers, N., Uamburu, N., & Ragin, C. (2021). Heterogeneity in head and neck cancer incidence among black populations from Africa, the Caribbean and the USA: Analysis of cancer registry data by the AC3. Cancer epidemiology, 75102053. https://doi.org/10.1016/j.canep.2021.102053
Auguste, Aviane, et al. "Heterogeneity in head and neck cancer incidence among black populations from Africa, the Caribbean and the USA: Analysis of cancer registry data by the AC3." Cancer epidemiology vol. 75 (2021): 102053. doi: https://doi.org/10.1016/j.canep.2021.102053
Auguste A, Gathere S, Pinheiro PS, Adebamowo C, Akintola A, Alleyne-Mike K, Anderson SG, Ashing K, Awittor FK, Awuah B, Bhakkan B, Deloumeaux J, du Plessis M, Ekanem IA, Ekanem U, Ezeome E, Felix N, Gachii AK, Gaete S, Gibson T, Hage R, Harrison S, Igbinoba F, Iseh K, Kiptanui E, Korir A, Lawson-Myers HD, Llanos A, Luce D, McNaughton D, Odutola M, Omonisi A, Otu T, Peruvien J, Raheem N, Roach V, Sobers N, Uamburu N, Ragin C. Heterogeneity in head and neck cancer incidence among black populations from Africa, the Caribbean and the USA: Analysis of cancer registry data by the AC3. Cancer Epidemiol. 2021 Dec;75:102053. doi: 10.1016/j.canep.2021.102053. Epub 2021 Nov 04. PMID: 34743058; PMCID: PMC8627451.
Copy Download .nbib Format: NLM
Murine BST2/tetherin promotes measles virus infection of neurons.

Virology

Miller KD, Matullo C, Williams R, Jones CB, Rall GF.
PMID: 34416448
Virology. 2021 Nov;563:38-43. doi: 10.1016/j.virol.2021.08.005. Epub 2021 Aug 15.

BST2/tetherin is a transmembrane protein with antiviral activity; it is synthesized following exposure to interferons, and restricts the release of budding virus particles by tethering them to the host cell membrane. We previously showed that BST2 is induced in...

Cite
Miller KD, Matullo C, Williams R, et al. Murine BST2/tetherin promotes measles virus infection of neurons. Virology. 2021;563:38-43doi: 10.1016/j.virol.2021.08.005.
Miller, K. D., Matullo, C., Williams, R., Jones, C. B., & Rall, G. F. (2021). Murine BST2/tetherin promotes measles virus infection of neurons. Virology, 56338-43. https://doi.org/10.1016/j.virol.2021.08.005
Miller, Katelyn D, et al. "Murine BST2/tetherin promotes measles virus infection of neurons." Virology vol. 563 (2021): 38-43. doi: https://doi.org/10.1016/j.virol.2021.08.005
Miller KD, Matullo C, Williams R, Jones CB, Rall GF. Murine BST2/tetherin promotes measles virus infection of neurons. Virology. 2021 Nov;563:38-43. doi: 10.1016/j.virol.2021.08.005. Epub 2021 Aug 15. PMID: 34416448; PMCID: PMC8491112.
Copy Download .nbib Format: NLM
CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis.

Cancer research

Laine A, Nagelli SG, Farrington C, Butt U, Cvrljevic AN, Vainonen JP, Feringa FM, Grönroos TJ, Gautam P, Khan S, Sihto H, Qiao X, Pavic K, Connolly DC, Kronqvist P, Elo LL, Maurer J, Wennerberg K, Medema RH, Joensuu H, Peuhu E, de Visser K, Narla G, Westermarck J.
PMID: 34145035
Cancer Res. 2021 Aug 15;81(16):4319-4331. doi: 10.1158/0008-5472.CAN-20-3651. Epub 2021 Jun 18.

Basal-like breast cancers (BLBC) are characterized by defects in homologous recombination (HR), deficient mitotic checkpoint, and high-proliferation activity. Here, we discover CIP2A as a candidate driver of BLBC. CIP2A was essential for DNA damage-induced initiation of mouse BLBC-like mammary...

Cite
Laine A, Nagelli SG, Farrington C, et al. CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis. Cancer Res. 2021;81(16):4319-4331doi: 10.1158/0008-5472.CAN-20-3651.
Laine, A., Nagelli, S. G., Farrington, C., Butt, U., Cvrljevic, A. N., Vainonen, J. P., Feringa, F. M., Grönroos, T. J., Gautam, P., Khan, S., Sihto, H., Qiao, X., Pavic, K., Connolly, D. C., Kronqvist, P., Elo, L. L., Maurer, J., Wennerberg, K., Medema, R. H., Joensuu, H., Peuhu, E., de Visser, K., Narla, G., & Westermarck, J. (2021). CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis. Cancer research, 81(16), 4319-4331. https://doi.org/10.1158/0008-5472.CAN-20-3651
Laine, Anni, et al. "CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis." Cancer research vol. 81,16 (2021): 4319-4331. doi: https://doi.org/10.1158/0008-5472.CAN-20-3651
Laine A, Nagelli SG, Farrington C, Butt U, Cvrljevic AN, Vainonen JP, Feringa FM, Grönroos TJ, Gautam P, Khan S, Sihto H, Qiao X, Pavic K, Connolly DC, Kronqvist P, Elo LL, Maurer J, Wennerberg K, Medema RH, Joensuu H, Peuhu E, de Visser K, Narla G, Westermarck J. CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis. Cancer Res. 2021 Aug 15;81(16):4319-4331. doi: 10.1158/0008-5472.CAN-20-3651. Epub 2021 Jun 18. PMID: 34145035; PMCID: PMC8373817.
Copy Download .nbib Format: NLM
Developmental timing of initial racial discrimination exposure is associated with cardiovascular health conditions in adulthood.

Ethnicity & health

Cuevas AG, Ho T, Rodgers J, DeNufrio D, Alley L, Allen J, Williams DR.
PMID: 31064206
Ethn Health. 2021 Oct;26(7):949-962. doi: 10.1080/13557858.2019.1613517. Epub 2019 May 07.

OBJECTIVE: To examine the association between developmental timing of initial exposure to racial discrimination and cardiovascular health conditions.DESIGN: Using data from the 1995 Detroit Area Study, logistic and negative binomial regression models were used to assess the association between...

Cite
Cuevas AG, Ho T, Rodgers J, et al. Developmental timing of initial racial discrimination exposure is associated with cardiovascular health conditions in adulthood. Ethn Health. 2019;26(7):949-962doi: 10.1080/13557858.2019.1613517.
Cuevas, A. G., Ho, T., Rodgers, J., DeNufrio, D., Alley, L., Allen, J., & Williams, D. R. (2021). Developmental timing of initial racial discrimination exposure is associated with cardiovascular health conditions in adulthood. Ethnicity & health, 26(7), 949-962. https://doi.org/10.1080/13557858.2019.1613517
Cuevas, Adolfo G, et al. "Developmental timing of initial racial discrimination exposure is associated with cardiovascular health conditions in adulthood." Ethnicity & health vol. 26,7 (2021): 949-962. doi: https://doi.org/10.1080/13557858.2019.1613517
Cuevas AG, Ho T, Rodgers J, DeNufrio D, Alley L, Allen J, Williams DR. Developmental timing of initial racial discrimination exposure is associated with cardiovascular health conditions in adulthood. Ethn Health. 2021 Oct;26(7):949-962. doi: 10.1080/13557858.2019.1613517. Epub 2019 May 07. PMID: 31064206; PMCID: PMC7026859.
Copy Download .nbib Format: NLM
Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Avkshtol V, Ruth KJ, Ross EA, Hallman MA, Greenberg RE, Price RA, Leachman B, Uzzo RG, Ma C, Chen D, Geynisman DM, Sobczak ML, Zhang E, Wong JK, Pollack A, Horwitz EM.
PMID: 32119599
J Clin Oncol. 2020 May 20;38(15):1676-1684. doi: 10.1200/JCO.19.01485. Epub 2020 Mar 02.

PURPOSE: The previously published single institution randomized prospective trial failed to show superiority in the 5-year biochemical and/or clinical disease failure (BCDF) rate with moderate hypofractionated intensity-modulated radiation therapy (H-IMRT) versus conventionally fractionated IMRT (C-IMRT). We now present 10-year...

Cite
Avkshtol V, Ruth KJ, Ross EA, et al. Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer. J Clin Oncol. 2020;38(15):1676-1684doi: 10.1200/JCO.19.01485.
Avkshtol, V., Ruth, K. J., Ross, E. A., Hallman, M. A., Greenberg, R. E., Price, R. A., Leachman, B., Uzzo, R. G., Ma, C., Chen, D., Geynisman, D. M., Sobczak, M. L., Zhang, E., Wong, J. K., Pollack, A., & Horwitz, E. M. (2020). Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 38(15), 1676-1684. https://doi.org/10.1200/JCO.19.01485
Avkshtol, Vladimir, et al. "Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 38,15 (2020): 1676-1684. doi: https://doi.org/10.1200/JCO.19.01485
Avkshtol V, Ruth KJ, Ross EA, Hallman MA, Greenberg RE, Price RA, Leachman B, Uzzo RG, Ma C, Chen D, Geynisman DM, Sobczak ML, Zhang E, Wong JK, Pollack A, Horwitz EM. Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer. J Clin Oncol. 2020 May 20;38(15):1676-1684. doi: 10.1200/JCO.19.01485. Epub 2020 Mar 02. PMID: 32119599; PMCID: PMC7238488.
Copy Download .nbib Format: NLM
Towards precision public health: Geospatial analytics and sensitivity/specificity assessments to inform liver cancer prevention.

SSM - population health

Lynch SM, Wiese D, Ortiz A, Sorice KA, Nguyen M, González ET, Henry KA.
PMID: 32885020
SSM Popul Health. 2020 Aug 07;12:100640. doi: 10.1016/j.ssmph.2020.100640. eCollection 2020 Dec.

OBJECTIVES: Liver cancer (LC) continues to rise, partially due to limited resources for prevention. To test the precision public health (PPH) hypothesis that fewer areas in need of LC prevention could be identified by combining existing surveillance data, we...

Cite
Lynch SM, Wiese D, Ortiz A, et al. Towards precision public health: Geospatial analytics and sensitivity/specificity assessments to inform liver cancer prevention. SSM Popul Health. 2020;12:100640doi: 10.1016/j.ssmph.2020.100640.
Lynch, S. M., Wiese, D., Ortiz, A., Sorice, K. A., Nguyen, M., González, E. T., & Henry, K. A. (2020). Towards precision public health: Geospatial analytics and sensitivity/specificity assessments to inform liver cancer prevention. SSM - population health, 12100640. https://doi.org/10.1016/j.ssmph.2020.100640
Lynch, Shannon M, et al. "Towards precision public health: Geospatial analytics and sensitivity/specificity assessments to inform liver cancer prevention." SSM - population health vol. 12 (2020): 100640. doi: https://doi.org/10.1016/j.ssmph.2020.100640
Lynch SM, Wiese D, Ortiz A, Sorice KA, Nguyen M, González ET, Henry KA. Towards precision public health: Geospatial analytics and sensitivity/specificity assessments to inform liver cancer prevention. SSM Popul Health. 2020 Aug 07;12:100640. doi: 10.1016/j.ssmph.2020.100640. eCollection 2020 Dec. PMID: 32885020; PMCID: PMC7451830.
Copy Download .nbib Format: NLM
Breast Implant-associated Anaplastic Large Cell Lymphoma: A Review with Emphasis on the Role of Brentuximab Vedotin.

Journal of cellular immunology

Stack A, Ali N, Khan N.
PMID: 32914146
J Cell Immunol. 2020 May;2(3):80-89. doi: 10.33696/immunology.2.025.

Breast implant-associated anaplastic large cell lymphoma is a recently recognized complication of textured breast implants. It typically presents as unilateral peri-implant swelling approximately 7-10 years after implantation. While the course is usually indolent, breast implant-associated anaplastic large cell lymphoma...

Cite
Stack A, Ali N, Khan N. Breast Implant-associated Anaplastic Large Cell Lymphoma: A Review with Emphasis on the Role of Brentuximab Vedotin. J Cell Immunol. 2020;2(3):80-89doi: 10.33696/immunology.2.025.
Stack, A., Ali, N., & Khan, N. (2020). Breast Implant-associated Anaplastic Large Cell Lymphoma: A Review with Emphasis on the Role of Brentuximab Vedotin. Journal of cellular immunology, 2(3), 80-89. https://doi.org/10.33696/immunology.2.025
Stack, Anthony, et al. "Breast Implant-associated Anaplastic Large Cell Lymphoma: A Review with Emphasis on the Role of Brentuximab Vedotin." Journal of cellular immunology vol. 2,3 (2020): 80-89. doi: https://doi.org/10.33696/immunology.2.025
Stack A, Ali N, Khan N. Breast Implant-associated Anaplastic Large Cell Lymphoma: A Review with Emphasis on the Role of Brentuximab Vedotin. J Cell Immunol. 2020 May;2(3):80-89. doi: 10.33696/immunology.2.025. PMID: 32914146; PMCID: PMC7480932.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 220 entries